Acadia Healthcare announced on Tuesday, October 7, 2025, that Todd Young will become the company’s chief financial officer, effective October 27, 2025. The appointment comes amid growing pressure from activist investors to strengthen governance and financial discipline. Interim CFO Tim Sides will revert to his role as Senior Vice President of Operations Finance.
Todd Young brings 25 years of executive‑level finance experience in the healthcare sector, most recently serving as CFO of Elanco Animal Health and previously as CFO of ACADIA Pharmaceuticals. His background includes building robust finance organizations, leading capital allocation strategies, and driving treasury and financial operations in publicly traded companies. The Business Wire release highlights his expertise in capital allocation, finance, and treasury, positioning him to support Acadia’s disciplined growth strategy.
The CFO appointment is a strategic shift that will influence Acadia’s financial management, capital deployment, and operational efficiency. Young’s experience is expected to enhance financial discipline, support the company’s expansion plans, and improve the execution of its disciplined growth strategy. This leadership change is significant for investors as it signals a renewed focus on financial governance and operational excellence.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.